Viking Therapeutics, Inc. (VKTX): 8-K filed Feb 11, 2026

Form type

8-K

Filing date

Feb 11, 2026

Accession number

0001193125-26-046536

Filer

Viking Therapeutics, Inc. (CIK 1607678)